Mass spectrometry can verify molecular identity, but it is expensive testing that most grey market suppliers do not perform or provide
These statements and the product have not been evaluated or approved by the Food and Drug Administration (FDA)
Armed with genetic insights, PlexusDx clinicians can recommend whether you'll respond better to semaglutide, tirzepatide, a dual-compound approach, or even PlexusDx's Microdose GLP-1 Protocol (starting at $129/month for patients with sensitivity concerns)
PLoS ONE 8 , e60773 (2013)
For broader options, see our Conditions Treated page
Rescue tirzepatide was used by 8% of the continued-dose group, 25% of the 5 mg group and 67% of the placebo group among participants assessed under the studys regain criteria